State officials in Massachusetts announced Tuesday that the state's pilot Narcon (naloxone) pilot program has marked the 1,000th overdose reversal since the program was introduced in 2007. The program is part of a broader effort undertaken by the Department of Public Health, its Bureau of Substance Abuse Services and its Bureau of Infectious Disease Control to reduce fatal and non-fatal opiate overdoses.
"Too many families have been impacted by the rise in opiate abuse and overdoses in Massachusetts," said Lieutenant Governor Timothy Murray, Chair of the Interagency Council on Substance Abuse and Prevention. "As we continue to combat opiate abuse and provide resources for prevention and treatment services, Narcan has proven to be a powerful tool in saving lives, so that opiate abusers can receive treatment and begin to recover from their addiction."
"Massachusetts is a national leader in opioid overdose prevention," said Secretary of Health and Human Services JudyAnn Bigby, MD. "By using community-based programs to enroll participants and distribute Intra-nasal Narcan, this pilot has allowed us to reach opioid users and bystanders in communities across the state."
Intra-nasal Narcan is available at pilot sites located in 12 Massachusetts cities, including Boston, Brockton, Cambridge, Fall River, Gloucester, Hyannis, Lynn, New Bedford, Northampton, Provincetown, Quincy and Springfield. The pilot sites provide education on overdose prevention, recognition and response to opiate users and family and friends of opiate users, along with referrals to treatment. Click here to learn more.